Licenze per i dossier - Gerot Lannach

Formulazione	Dosaggio	Status	Forma farmaceutica
Ampoules	0.02 mg/ml (5 ml)	Available
Indicazioni: Linfoma Cutaneo a cellule T (CTCL)

Ampoules 0.02 mg/ml (5 ml)	Available
Indicazioni: Linfoma Cutaneo a cellule T (CTCL)

Acetylsalicylsäure (ASS)

Formulazione	Dosaggio	Status	Forma farmaceutica
Gastro-resistant tablets	75 mg	Available
Gastro-resistant tablets	100 mg	Available
Gastro-resistant tablets	160 mg	Available
Tablets	75 mg	Available
Tablets	100 mg	Available
Indicazioni: Antithrombotika

Gastro-resistant tablets 75 mg	Available
Gastro-resistant tablets 100 mg	Available
Gastro-resistant tablets 160 mg	Available
Tablets 75 mg	Available
Tablets 100 mg	Available
Indicazioni: Antithrombotika

Benfotiamine

Formulazione	Dosaggio	Status	Forma farmaceutica
Film-coated tablets	50 mg	Available
Film-coated tablets	150 mg	Available
Film-coated tablets	300 mg	Available
Indicazioni: Vitamin B1 Deficiency

Film-coated tablets 50 mg	Available
Film-coated tablets 150 mg	Available
Film-coated tablets 300 mg	Available
Indicazioni: Vitamin B1 Deficiency

Brivaracetam

Formulazione	Dosaggio	Status	Forma farmaceutica
Film-coated tablets	10 mg	Q1 2024
Film-coated tablets	25 mg	Q1 2024
Film-coated tablets	50 mg	Q1 2024
Film-coated tablets	75 mg	Q1 2024
Film-coated tablets	100 mg	Q1 2024
Indicazioni: Epilepsy

Film-coated tablets 10 mg	Q1 2024
Film-coated tablets 25 mg	Q1 2024
Film-coated tablets 50 mg	Q1 2024
Film-coated tablets 75 mg	Q1 2024
Film-coated tablets 100 mg	Q1 2024
Indicazioni: Epilepsy

Buprenorphine

Formulazione	Dosaggio	Status	Forma farmaceutica
Compresse sublinguali	1 mg	Available
Compresse sublinguali	2 mg	Available
Compresse sublinguali	4 mg	Available
Compresse sublinguali	6 mg	Available
Compresse sublinguali	8 mg	Available
Compresse sublinguali	12 mg	Available
Compresse sublinguali	16 mg	Available
Compresse sublinguali	0.2 mg	Q2 2023
Compresse sublinguali	0.4 mg	Q2 2023
Indicazioni: Opioid Use Disorder

Compresse sublinguali 1 mg	Available
Compresse sublinguali 2 mg	Available
Compresse sublinguali 4 mg	Available
Compresse sublinguali 6 mg	Available
Compresse sublinguali 8 mg	Available
Compresse sublinguali 12 mg	Available
Compresse sublinguali 16 mg	Available
Compresse sublinguali 0.2 mg	Q2 2023
Compresse sublinguali 0.4 mg	Q2 2023
Indicazioni: Opioid Use Disorder

Buprenorphine + Naloxone

Formulazione	Dosaggio	Status	Forma farmaceutica
Compresse sublinguali	2 mg+0.5 mg	Available
Compresse sublinguali	4 mg+1 mg	Available
Compresse sublinguali	8 mg+2 mg	Available
Compresse sublinguali	1 mg+0.25 mg	Q4 2023
Compresse sublinguali	12 mg+3 mg	Q4 2023
Compresse sublinguali	16 mg+4 mg	Q4 2023
Indicazioni: Opioid Use Disorder

Compresse sublinguali 2 mg+0.5 mg	Available
Compresse sublinguali 4 mg+1 mg	Available
Compresse sublinguali 8 mg+2 mg	Available
Compresse sublinguali 1 mg+0.25 mg	Q4 2023
Compresse sublinguali 12 mg+3 mg	Q4 2023
Compresse sublinguali 16 mg+4 mg	Q4 2023
Indicazioni: Opioid Use Disorder

Candesartan + Chlortalidone

Formulazione	Dosaggio	Status	Forma farmaceutica
Tablets	8 mg+12.5 mg	2024
Tablets	16 mg+12.5 mg	2024
Tablets	32 mg+12.5 mg	2024
Tablets	32 mg+25 mg	2024
Indicazioni: High Blood Pressure

Tablets 8 mg+12.5 mg	2024
Tablets 16 mg+12.5 mg	2024
Tablets 32 mg+12.5 mg	2024
Tablets 32 mg+25 mg	2024
Indicazioni: High Blood Pressure

Esketamine

Formulazione	Dosaggio	Status	Forma farmaceutica
Solution for injection or infusion	5 mg/ml (2 ml, 5 ml, 10 ml)	Available
Solution for injection or infusion	25 mg/ml (2 ml, 5 ml, 10 ml)	Available
Solution for injection or infusion	5 mg/ml (5 ml, 10 ml, 20 ml)	Available
Solution for injection or infusion	25 mg/ml (5 ml, 10 ml, 20 ml)	Available
Indicazioni: Narcotic, Severe Pain

Solution for injection or infusion 5 mg/ml (2 ml, 5 ml, 10 ml)	Available
Solution for injection or infusion 25 mg/ml (2 ml, 5 ml, 10 ml)	Available
Solution for injection or infusion 5 mg/ml (5 ml, 10 ml, 20 ml)	Available
Solution for injection or infusion 25 mg/ml (5 ml, 10 ml, 20 ml)	Available
Indicazioni: Narcotic, Severe Pain

Eslicarbazepine

Formulazione	Dosaggio	Status	Forma farmaceutica
Tablets	200 mg	Available
Tablets	400 mg	Available
Tablets	600 mg	Available
Tablets	800 mg	Available
Indicazioni: Epilepsy

Tablets 200 mg	Available
Tablets 400 mg	Available
Tablets 600 mg	Available
Tablets 800 mg	Available
Indicazioni: Epilepsy

Eszopiclone

Formulazione	Dosaggio	Status	Forma farmaceutica
Film-coated tablets	1 mg	Available
Film-coated tablets	2 mg	Available
Film-coated tablets	3 mg	Available
Indicazioni: Insomnia

Film-coated tablets 1 mg	Available
Film-coated tablets 2 mg	Available
Film-coated tablets 3 mg	Available
Indicazioni: Insomnia

Ethosuximide

Formulazione	Dosaggio	Status	Forma farmaceutica
Syrup	50 mg/ml (250 ml)	-
Indicazioni: Epilepsy

Syrup 50 mg/ml (250 ml)	-
Indicazioni: Epilepsy

Fe²⁺ + Ascorbic Acid (Ferretab^®)

Formulazione	Dosaggio	Status	Forma farmaceutica
Capsules	100 mg+20 mg	Dossier update pending
Indicazioni: Anaemia

Capsules 100 mg+20 mg	Dossier update pending
Indicazioni: Anaemia

Fe²⁺ + Ascorbic Acid+ Folic Acid (Ferretab^® comp plus)

Formulazione	Dosaggio	Status	Forma farmaceutica
Capsules	66.7 mg+100 mg+0.8 mg	Available
Indicazioni: Anaemia during Pregnancy

Capsules 66.7 mg+100 mg+0.8 mg	Available
Indicazioni: Anaemia during Pregnancy

Fe²⁺ + Folic Acid (Ferretab^® comp)

Formulazione	Dosaggio	Status	Forma farmaceutica
Capsules	50 mg+0.5 mg	Dossier update pending
Indicazioni: Anaemia during Pregnancy

Capsules 50 mg+0.5 mg	Dossier update pending
Indicazioni: Anaemia during Pregnancy

Fluoxetine

Formulazione	Dosaggio	Status	Forma farmaceutica
Film-coated tablets	20 mg	Available
Film-coated tablets	40 mg	Available
Indicazioni: Depression

Film-coated tablets 20 mg	Available
Film-coated tablets 40 mg	Available
Indicazioni: Depression

Folic Acid

Formulazione	Dosaggio	Status	Forma farmaceutica
Tablets	1 mg	Available
Tablets	5 mg	Available
Indicazioni: Folic Acid Deficiency

Tablets 1 mg	Available
Tablets 5 mg	Available
Indicazioni: Folic Acid Deficiency

Hydromorphone

Formulazione	Dosaggio	Status	Forma farmaceutica
Solution for injection	2 mg/ml (1 ml)	Available
Solution for injection	10 mg/ml (1 ml, 10 ml)	Available
Solution for injection	20 mg/ml (1 ml)	Available
Solution for injection	50 mg/ml (1 ml)	Available
Film-coated tablets	1.3 mg	Q3 2023
Film-coated tablets	2.6 mg	Q3 2023
Indicazioni: Severe Pain

Solution for injection 2 mg/ml (1 ml)	Available
Solution for injection 10 mg/ml (1 ml, 10 ml)	Available
Solution for injection 20 mg/ml (1 ml)	Available
Solution for injection 50 mg/ml (1 ml)	Available
Film-coated tablets 1.3 mg	Q3 2023
Film-coated tablets 2.6 mg	Q3 2023
Indicazioni: Severe Pain

Hydroxocobalamine

Formulazione	Dosaggio	Status	Forma farmaceutica
Solution for injection	1 mg/ml (1 ml)	Available
Indicazioni: Vitamin B12 Deficiency

Solution for injection 1 mg/ml (1 ml)	Available
Indicazioni: Vitamin B12 Deficiency

Ketamine

Formulazione	Dosaggio	Status	Forma farmaceutica
Solution for injection or infusion	10 mg/ml (2 ml, 5 ml, 10 ml)	Available
Solution for injection or infusion	50 mg/ml (2 ml, 5 ml, 10 ml)	Available
Solution for injection or infusion	10 mg/ml (5 ml, 10 ml, 20 ml)	Available
Solution for injection or infusion	50 mg/ml (5 ml, 10 ml, 20 ml)	Available
Indicazioni: Narcotic, Severe Pain

Solution for injection or infusion 10 mg/ml (2 ml, 5 ml, 10 ml)	Available
Solution for injection or infusion 50 mg/ml (2 ml, 5 ml, 10 ml)	Available
Solution for injection or infusion 10 mg/ml (5 ml, 10 ml, 20 ml)	Available
Solution for injection or infusion 50 mg/ml (5 ml, 10 ml, 20 ml)	Available
Indicazioni: Narcotic, Severe Pain

Lacosamide

Formulazione	Dosaggio	Status	Forma farmaceutica
Film-coated tablets	50 mg	Available
Film-coated tablets	100 mg	Available
Film-coated tablets	150 mg	Available
Film-coated tablets	200 mg	Available
Oral solution	10 mg/ml (200 ml, 500 ml)	Available
Solution for infusion	10 mg/ml (10 ml, 20 ml)	Available
Solution for infusion	10 mg/ml (20 ml)	Available
Indicazioni: Epilepsy

Film-coated tablets 50 mg	Available
Film-coated tablets 100 mg	Available
Film-coated tablets 150 mg	Available
Film-coated tablets 200 mg	Available
Oral solution 10 mg/ml (200 ml, 500 ml)	Available
Solution for infusion 10 mg/ml (10 ml, 20 ml)	Available
Solution for infusion 10 mg/ml (20 ml)	Available
Indicazioni: Epilepsy

Levetiracetam

Formulazione	Dosaggio	Status	Forma farmaceutica
Oral solution	100 mg/ml (150 ml, 300 ml)	Available
Concentration for solution for infusion	100 mg/ml (5 ml)	Available
Indicazioni: Epilepsy

Oral solution 100 mg/ml (150 ml, 300 ml)	Available
Concentration for solution for infusion 100 mg/ml (5 ml)	Available
Indicazioni: Epilepsy

Levomethadone

Formulazione	Dosaggio	Status	Forma farmaceutica
Tablets	2.5 mg	Available
Tablets	5 mg	Available
Tablets	10 mg	Available
Tablets	20 mg	Available
Tablets	30 mg	Available
Concentration for oral solution	5 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000ml)	Available
Indicazioni: Opioid Use Disorder

Tablets 2.5 mg	Available
Tablets 5 mg	Available
Tablets 10 mg	Available
Tablets 20 mg	Available
Tablets 30 mg	Available
Concentration for oral solution 5 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000ml)	Available
Indicazioni: Opioid Use Disorder

Metamizole

Formulazione	Dosaggio	Status	Forma farmaceutica
Solution for injection	500 mg/ml (2 ml, 5 ml)	Available
Film-coated tablets	500 mg	2024
Film-coated tablets	1000 mg	2024
Indicazioni: Mild to Moderate Pain

Solution for injection 500 mg/ml (2 ml, 5 ml)	Available
Film-coated tablets 500 mg	2024
Film-coated tablets 1000 mg	2024
Indicazioni: Mild to Moderate Pain

Methadone

Formulazione	Dosaggio	Status	Forma farmaceutica
Tablets	5 mg	Available
Tablets	10 mg	Available
Tablets	20 mg	Available
Tablets	40 mg	Available
Tablets	60 mg	Available
Concentration for oral solution	10 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000 ml)	Available
Indicazioni: Opioid Use Disorder

Tablets 5 mg	Available
Tablets 10 mg	Available
Tablets 20 mg	Available
Tablets 40 mg	Available
Tablets 60 mg	Available
Concentration for oral solution 10 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000 ml)	Available
Indicazioni: Opioid Use Disorder

Metoclopramide

Formulazione	Dosaggio	Status	Forma farmaceutica
Oral solution	1 mg/ml (150 ml)	Available
Solution for injection or infusion	5 mg/ml (2 ml, 10 ml)	Available
Indicazioni: Emesis, Nausea

Oral solution 1 mg/ml (150 ml)	Available
Solution for injection or infusion 5 mg/ml (2 ml, 10 ml)	Available
Indicazioni: Emesis, Nausea

Morphine

Formulazione	Dosaggio	Status	Forma farmaceutica
Solution for injection	10 mg/ml (1 ml)	Available
Solution for injection	10 mg/ml (10 ml)	Available
Solution for injection	20 mg/ml (10 ml)	Available
Indicazioni: Severe Pain

Solution for injection 10 mg/ml (1 ml)	Available
Solution for injection 10 mg/ml (10 ml)	Available
Solution for injection 20 mg/ml (10 ml)	Available
Indicazioni: Severe Pain

Oxycodone

Formulazione	Dosaggio	Status	Forma farmaceutica
Film-coated tablets	5 mg	Available
Film-coated tablets	10 mg	Available
Film-coated tablets	20 mg	Available
Prolonged-release tablets	5 mg	Available
Prolonged-release tablets	10 mg	Available
Prolonged-release tablets	15 mg	Available
Prolonged-release tablets	20 mg	Available
Prolonged-release tablets	30 mg	Available
Prolonged-release tablets	40 mg	Available
Prolonged-release tablets	60 mg	Available
Prolonged-release tablets	80 mg	Available
Oral solution	1 mg/ml (100 ml, 250 ml, 300 ml)	Available
Oral solution	10 mg/ml (30 ml, 100 ml, 120 ml)	Available
Solution for injection or infusion	10 mg/ml (1 ml, 2 ml)	Available
Indicazioni: Severe Pain

Film-coated tablets 5 mg	Available
Film-coated tablets 10 mg	Available
Film-coated tablets 20 mg	Available
Prolonged-release tablets 5 mg	Available
Prolonged-release tablets 10 mg	Available
Prolonged-release tablets 15 mg	Available
Prolonged-release tablets 20 mg	Available
Prolonged-release tablets 30 mg	Available
Prolonged-release tablets 40 mg	Available
Prolonged-release tablets 60 mg	Available
Prolonged-release tablets 80 mg	Available
Oral solution 1 mg/ml (100 ml, 250 ml, 300 ml)	Available
Oral solution 10 mg/ml (30 ml, 100 ml, 120 ml)	Available
Solution for injection or infusion 10 mg/ml (1 ml, 2 ml)	Available
Indicazioni: Severe Pain

Oxycodone + Naloxone

Formulazione	Dosaggio	Status	Forma farmaceutica
Prolonged-release tablets	5 mg+2.5 mg	Available
Prolonged-release tablets	10 mg+5 mg	Available
Prolonged-release tablets	20 mg+10 mg	Available
Prolonged-release tablets	30 mg+15 mg	Available
Prolonged-release tablets	40 mg+20 mg	Available
Indicazioni: Severe Pain

Prolonged-release tablets 5 mg+2.5 mg	Available
Prolonged-release tablets 10 mg+5 mg	Available
Prolonged-release tablets 20 mg+10 mg	Available
Prolonged-release tablets 30 mg+15 mg	Available
Prolonged-release tablets 40 mg+20 mg	Available
Indicazioni: Severe Pain

Perampanel

Formulazione	Dosaggio	Status	Forma farmaceutica
Film-coated tablets	2 mg	Available
Film-coated tablets	4 mg	Available
Film-coated tablets	6 mg	Available
Film-coated tablets	8 mg	Available
Film-coated tablets	10 mg	Available
Film-coated tablets	12 mg	Available
Indicazioni: Epilepsy

Film-coated tablets 2 mg	Available
Film-coated tablets 4 mg	Available
Film-coated tablets 6 mg	Available
Film-coated tablets 8 mg	Available
Film-coated tablets 10 mg	Available
Film-coated tablets 12 mg	Available
Indicazioni: Epilepsy

Potassium Iodide

Formulazione	Dosaggio	Status	Forma farmaceutica
Tablets	65 mg	Available
Indicazioni: Radiation Prophylaxis

Tablets 65 mg	Available
Indicazioni: Radiation Prophylaxis

Tapentadol

Formulazione	Dosaggio	Status	Forma farmaceutica
Film-coated tablets	25 mg	Available
Film-coated tablets	50 mg	Available
Film-coated tablets	75 mg	Available
Film-coated tablets	100 mg	Available
Oral solution	20 mg/ml (100 ml, 200 ml)	Available
Prolonged-release tablets	25 mg	Available
Prolonged-release tablets	50 mg	Available
Prolonged-release tablets	100 mg	Available
Prolonged-release tablets	150 mg	Available
Prolonged-release tablets	200 mg	Available
Prolonged-release tablets	250 mg	Available
Indicazioni: Severe Pain

Film-coated tablets 25 mg	Available
Film-coated tablets 50 mg	Available
Film-coated tablets 75 mg	Available
Film-coated tablets 100 mg	Available
Oral solution 20 mg/ml (100 ml, 200 ml)	Available
Prolonged-release tablets 25 mg	Available
Prolonged-release tablets 50 mg	Available
Prolonged-release tablets 100 mg	Available
Prolonged-release tablets 150 mg	Available
Prolonged-release tablets 200 mg	Available
Prolonged-release tablets 250 mg	Available
Indicazioni: Severe Pain

Tizanidine

Formulazione	Dosaggio	Status	Forma farmaceutica
Tablets	2 mg	Available
Tablets	4 mg	Available
Tablets	6 mg	Available
Indicazioni: Muscle Spasms

Tablets 2 mg	Available
Tablets 4 mg	Available
Tablets 6 mg	Available
Indicazioni: Muscle Spasms

Tramadol

Formulazione	Dosaggio	Status	Forma farmaceutica
Solution for injection	50 mg/ml (2 ml)	Dossier update pending
Oral drops	100 mg/ml (10 ml, 30 ml, 50 ml)	Dossier update pending
Indicazioni: Moderate to Severe Pain

Solution for injection 50 mg/ml (2 ml)	Dossier update pending
Oral drops 100 mg/ml (10 ml, 30 ml, 50 ml)	Dossier update pending
Indicazioni: Moderate to Severe Pain

Trazodone

Formulazione	Dosaggio	Status	Forma farmaceutica
Oral solution	10 mg/ml (120 ml)	Available
Prolonged-release tablets	75 mg	2025
Prolonged-release tablets	150 mg	2025
Indicazioni: Depression

Oral solution 10 mg/ml (120 ml)	Available
Prolonged-release tablets 75 mg	2025
Prolonged-release tablets 150 mg	2025
Indicazioni: Depression

Valproic Acid/Sodium Valproate

Formulazione	Dosaggio	Status	Forma farmaceutica
Oral solution	300 mg/ml (100 ml)	Available
Prolonged-release tablets	300 mg	2024
Prolonged-release tablets	500 mg	2024
Gastro-resistant soft capsules	150 mg	Dossier update pending
Gastro-resistant soft capsules	300 mg	Dossier update pending
Gastro-resistant soft capsules	500 mg	Dossier update pending
Syrup	50 mg/ml (100 ml)	Dossier update pending
Solution for injection	100 mg/ml (5 ml)	Dossier update pending
Indicazioni: Epilepsy

Oral solution 300 mg/ml (100 ml)	Available
Prolonged-release tablets 300 mg	2024
Prolonged-release tablets 500 mg	2024
Gastro-resistant soft capsules 150 mg	Dossier update pending
Gastro-resistant soft capsules 300 mg	Dossier update pending
Gastro-resistant soft capsules 500 mg	Dossier update pending
Syrup 50 mg/ml (100 ml)	Dossier update pending
Solution for injection 100 mg/ml (5 ml)	Dossier update pending
Indicazioni: Epilepsy

Vitamin B1/B6/B12 (Neuromultivit^®)

Formulazione	Dosaggio	Status	Forma farmaceutica
Film-coated tablets	100 mg+200 mg+0.2 mg	Dossier update pending
Solution for injection	50 mg+50 mg+0.5 mg/ml (2 ml)	Dossier update pending
Indicazioni: Neuropathic Pain, Vitamin B Deficiency

Film-coated tablets 100 mg+200 mg+0.2 mg	Dossier update pending
Solution for injection 50 mg+50 mg+0.5 mg/ml (2 ml)	Dossier update pending
Indicazioni: Neuropathic Pain, Vitamin B Deficiency

Vitamin D3

Formulazione	Dosaggio	Status	Forma farmaceutica
Oral solution	14 400 IU/ml (12.5 ml, 30 ml)	Available
Oral solution	28 800 IU/ml (12.5 ml, 30 ml, 50 ml)	Available
Indicazioni: Vitamin D3 Deficiency

Oral solution 14 400 IU/ml (12.5 ml, 30 ml)	Available
Oral solution 28 800 IU/ml (12.5 ml, 30 ml, 50 ml)	Available
Indicazioni: Vitamin D3 Deficiency

Licenze per i dossier Ultimo aggiornamento: Q1 2023

Licenze per i dossier
Ultimo aggiornamento: Q1 2023